Future work is necessary to address whether targeting MCP‐1 by decreasing body fat and/or attenuating inflammation pre‐operatively leads to better outcomes, particularly in older adults, as adipose tissue appears intimately involved with diabetes and cardiovascular disease. The gene discussed is CCL2; the disease is diabetes mellitus.